Skip to content


  • Retraction Note
  • Open Access

Retraction Note: Growth inhibition and apoptosis induced by 6-fluoro-3-formylchromone in hepatocellular carcinoma

  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1 and
  • 1Email author
BMC Gastroenterology201515:39

  • Received: 23 January 2015
  • Accepted: 23 January 2015
  • Published:

The original article was published in BMC Gastroenterology 2014 14:62


The Publisher and Editor regretfully retract this article [1] because the peer-review process was inappropriately influenced and compromised. As a result, the scientific integrity of the article cannot be guaranteed. A systematic and detailed investigation suggests that a third party was involved in supplying fabricated details of potential peer reviewers for a large number of manuscripts submitted to different journals. In accordance with recommendations from COPE we have retracted all affected published articles, including this one. It was not possible to determine beyond doubt that the authors of this particular article were aware of any third party attempts to manipulate peer review of their manuscript.


Authors’ Affiliations

Department of General Surgery, Changhai Hospital, No.168 Changhai Road, Yangpu District, 200433 Shanghai, China


  1. Zhang Y, Zheng K, Yan H, Jin G, Shao C, Zhou X, et al. Growth inhibition and apoptosis induced by 6-fluoro-3-formylchromone in hepatocellular carcinoma. BMC Gastroenterol. 2014;14:62.View ArticlePubMedPubMed CentralGoogle Scholar


© Zhang; licensee BioMed Central. 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.